The urgency of the work stems from a sobering arithmetic of plastic waste. At the end of a plastic product’s lifecycle, roughly 9 percent is recycled, 12 percent is incinerated, and the remaining 79 percent ends up in landfills or the natural environment, where thermal, ultraviolet, mechanical, and biological stresses slowly fracture items into ever-smaller fragments. These micro- and nanoplastics, defined as anthropogenic organic polymers with diameters or lengths spanning from the nanometer scale up to a few micrometers, have now been documented in virtually every trophic environment on Earth. While ingestion has traditionally dominated public concern, inhalation is increasingly recognized as a primary human exposure route, and it is the route for which laboratory models have remained, in the authors’ words, inconsistent and uncharacterized — a deficiency that weakens study power and compromises the reliability of results across the field.

To close that gap, the team turned to a whole-body rodent inhalation facility and a deliberately unglamorous test material: a commercially available, food-grade polyamide-12, or PA-12, bulk microparticle powder. PA-12 is a nylon-family polymer common in consumer goods, making it a realistic surrogate for the particles people actually encounter. But before a single animal breathed a single particle, the bulk powder was subjected to an unusually rigorous forensic characterization. Pyrolysis–gas chromatography–mass spectrometry, or PY-GC-MS, was used to confirm the material’s polymer chemistry by thermally breaking the plastic into identifiable fragments; attenuated total reflectance–Fourier-transform infrared spectroscopy, ATR-FTIR, provided an independent chemical fingerprint of the polymer bonds; and helium ion microscopy, HIM, resolved the particles’ true size and surface morphology at nanometer resolution.

That triple-verification step proved to be far more than bureaucratic caution. The manufacturer’s specification sheet reported an average particle size of about 5 micrometers, plus or minus 1 micrometer — squarely in the microparticle range. Yet when the researchers aerosolized the powder and measured what was actually airborne inside the exposure chamber, the reality was startlingly different. The in-house characterization revealed particles well within the nano-range, with average geometric mean diameters of less than 200 nanometers and aerodynamic peak-mode values below 100 nanometers at every concentration tested. In other words, the very material sold as a microparticle benchmark behaves, once airborne, as a nanoparticle-laden aerosol. The finding carries implications far beyond this single study: any laboratory that relies on supplier size claims without independent aerosol characterization may be dramatically misjudging the dose — and the deposition site — its animals are receiving.

The aerosols were generated and held at three mass concentrations designed to span both environmental and occupational exposure scenarios: a low level of 1.01 milligrams per cubic meter with a standard deviation of 0.17, a mid-level of 5.05 milligrams per cubic meter plus or minus 0.5, and a high level of 9.98 milligrams per cubic meter with a standard deviation of 3.14. Monitoring these distributions demanded an arsenal of overlapping instrumentation, because no single detector can faithfully cover four orders of magnitude in particle size. A scanning mobility particle sizer, SMPS, classified particles by their electrical mobility in the nanometer range; an aerodynamic particle sizer, APS, covered the micrometer range by measuring how particles accelerate in flowing air; and a high-resolution electrical low-pressure impactor, the HR-ELPI+, bridged the two regimes, together capturing the full spectrum from 10 nanometers to 20 micrometers in real time. Multi-day studies were then run to quantify intra-day and inter-day variability across several summary statistics of the size distributions, ensuring the exposure was not a lucky snapshot but a reproducible, characterizable condition.

When the instrument streams were merged, a bi- and tri-modal size distribution emerged, with geometric mean diameters spanning both the nano- and micro-ranges at all three concentrations. That multimodality matters because particle size dictates everything downstream: where in the respiratory tract a particle deposits, how quickly it is cleared, whether it dissolves or translocates, and what cells it ultimately contacts. An aerosol with distinct modes can deposit in distinct lung compartments simultaneously, and models that average that complexity away risk missing the biology entirely.

This is where the study’s computational component enters. The measured size distributions and concentration data were fed into the Multiple-Path Particle Dosimetry, or MPPD, model — widely used software that simulates how inhaled particles deposit along the branching anatomy of the respiratory tract, from the nose and throat through the bronchial tree and into the alveolar depths. The team ran the model for both Sprague-Dawley rats, the standard rodent toxicology workhorse, and for humans, seeking to estimate theoretical in silico exposures that could anchor the laboratory work to real-world health risk assessment. The outcome was quietly reassuring for the field: pulmonary tract deposition predicted by the model showed no significant physiological differences between the rat and human models, and deposition patterns did not differ between the low- and high-dose scenarios in a way that would complicate cross-species extrapolation. In practical terms, a rat breathing these particles deposits them in lung regions functionally comparable to those in a breathing human — a validation that strengthens the translational value of every rodent inhalation study built on this platform.

The significance of that alignment is hard to overstate. Dose translation between rodents and humans has long been a stumbling block for particle toxicology, and regulators have repeatedly flagged the weakness of uncharacterized exposure systems as a reason to treat microplastic health findings with caution. By combining verified polymer chemistry, independently measured airborne size distributions spanning the nano-scale, quantified day-to-day variability, controlled mass concentrations spanning realistic exposure tiers, and validated dosimetry modeling in both species, the team has assembled what amounts to a quality-assurance chain for inhalation toxicology — each link documented, reproducible, and open access for any laboratory to adopt.

The study also adds to a rapidly accumulating body of evidence on plastic inhalation specifically. Related recent work from the same research ecosystem has shown that a single inhalation exposure to polyamide micro- and nanoplastic particles can impair vascular dilation without generating pulmonary inflammation in virgin female Sprague-Dawley rats, while companion studies have tracked lung retention, distribution, and persistence of polymer particles in rats following inhalation. Broader efforts toward a risk-assessment framework for micro- and nanoplastic particles in human health have called for exactly the kind of standardized, characterized exposure methodology this paper now provides, suggesting the new protocol may become a reference point as agencies begin the difficult work of setting inhalation-based exposure limits.

For the public, the takeaway is both unsettling and constructive. The plastics we shed into the environment do not stay on the ground or in the water; they fragment into sizes light enough to ride air currents, and the particles suspended in a laboratory chamber from a food-grade powder measured far smaller than their label promised. What this study offers is not a new alarm but a tool — a rigorous, transparent, and characterizable way to find out precisely what those airborne fragments do once they reach the deepest reaches of the lung, in both rats and, by validated extension, in us. As the authors conclude, the methodology provides a foundation for controlled laboratory-based assessments of micro- and nanoplastic toxicity and risk over a range of environmental and occupational doses, and it arrives at a moment when the field desperately needs one.